ENDRA Life Sciences Inc. - FORM 10-K - EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - March 20, 2018

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - ENDRA Life Sciences Inc.ndra_ex312.htm
EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - ENDRA Life Sciences Inc.ndra_ex321.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - ENDRA Life Sciences Inc.ndra_ex311.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - ENDRA Life Sciences Inc.ndra_ex211.htm
EX-10.19 - CONSULTING AGREEMENT - ENDRA Life Sciences Inc.ndra_ex1019.htm
EX-10.18 - MASTER SERVICES AGREEMENT - ENDRA Life Sciences Inc.ndra_ex1018.htm
10-K - ANNUAL REPORT - ENDRA Life Sciences Inc.ndra_10k.htm
 
EXHIBIT 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
To the Board of Directors and
Stockholders of ENDRA Life Sciences Inc.
 
We consent to the incorporation by reference in the registration statement (File Number: 333-218894) on Form S-8 of ENDRA Life Sciences Inc. of our report dated March 19, 2018, which includes an explanatory paragraph as to the Company's ability to continue as a going concern, relating to the balance sheets of ENDRA Life Sciences Inc. as of December 31, 2017 and 2016, and the related statements of operations, stockholders’ equity (deficit) and cash flows for the years then ended, appearing in this Annual Report on Form 10-K of ENDRA Life Sciences Inc.
 
 
/s/ RBSM LLP
 
 
Henderson, NV
 
March 20, 2018
 
 
 
  
 

ENDRA Life Sciences Inc. Reports